ID
45611
Descripción
Principal Investigator: Glen J Weiss, MD, Cancer Treatment Centers of America, Goodyear, AZ, USA MeSH: Small Cell Lung Carcinoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001366 In this prospective study, custom genome-wide exome and whole transcriptome sequencing (NGS) was used to identify genomic events and associated expression changes in advanced Small Cell Lung Cancer (SCLC) and attempt to prescribe systemic therapy based on the results. Tumor/normal pairs were sequenced from 12 patients with advanced SCLC for this study.
Link
Palabras clave
Versiones (1)
- 22/2/23 22/2/23 - Chiara Middel
Titular de derechos de autor
Glen J Weiss, MD, Cancer Treatment Centers of America, Goodyear, AZ, USA
Subido en
22 de febrero de 2023
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
dbGaP phs001366 Pilot Study of Exome and mRNA Profiling in Small Cell Lung Cancer Patients
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs and consent information.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.
- This subject phenotype table contains subject ID, age, sex, ethnicity, KPS score, biopsy site, and smoke history.
- This sample attributes table contains sample ID, body site where sample was collected, analyte type, tumor status, histological type, and name of the center which conducted sequencing.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs and consent information.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.
- This subject phenotype table contains subject ID, age, sex, ethnicity, KPS score, biopsy site, and smoke history.
- This sample attributes table contains sample ID, body site where sample was collected, analyte type, tumor status, histological type, and name of the center which conducted sequencing.
C0680251 (UMLS CUI [1,2])
C0001779 (UMLS CUI [1,2])
C2586066 (UMLS CUI [1,3])
C0027651 (UMLS CUI [1,4])
C0005558 (UMLS CUI [1,5])
C1512693 (UMLS CUI [2,1])
C0206065 (UMLS CUI [2,2])
C0023671 (UMLS CUI [2,3])
C1442488 (UMLS CUI [2,4])
C1254595 (UMLS CUI [2,5])
C0205411 (UMLS CUI [2,6])
C0005953 (UMLS CUI [2,7])
C0232804 (UMLS CUI [2,8])
C0232741 (UMLS CUI [2,9])
C0680251 (UMLS CUI [3,1])
C0231220 (UMLS CUI [3,2])
C0332155 (UMLS CUI [3,3])
C0220650 (UMLS CUI [3,4])
C0205177 (UMLS CUI [3,5])
C0009450 (UMLS CUI [3,6])
C1514873 (UMLS CUI [3,7])
C0338237 (UMLS CUI [3,8])
C0205373 (UMLS CUI [3,9])
C0032961 (UMLS CUI [3,10])
C0006147 (UMLS CUI [3,11])
C0027651 (UMLS CUI [3,12])
C0005558 (UMLS CUI [3,13])
C4743675 (UMLS CUI [3,14])
C1298908 (UMLS CUI [4,1])
C0680251 (UMLS CUI [4,2])
C2348568 (UMLS CUI [4,3])
C0008976 (UMLS CUI [4,4])